The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obese), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Contrave can also be taken by: Adults looking for mild to moderate weight loss People who also have depression or binge eating disorder, Contrave may help with mood and cravings Those who prefer taking a daily pill instead of weekly injections Only approved for use in adults (18 and older) If you prefer tablets over injections or do not require significant weight loss (above 10%), Contrave may be right for you
September 1, 2025
Kipnis (1964) showed that gastrointestinal factors were indeed responsible for the extra insulin secreted after oral glucose, and that this mechanism was markedly impaired in patients with type 2 diabetes ( [31] ) ( [27] )
However, when analyzed by drug class, GLP1RAs almost halved the odds of all-cause dementia (OR = 0.55
Regular use could slowly make your skin look brighter and even out the tone, as well as fade dark spots
GLP-1 analogues, like semaglutide (Wegovy), liraglutide (Ozempic), oral semaglutide (Rybelsus), retatrutide, and tirzepatide, have garnered attention for their remarkable impact on weight management